Full title: TARGET BP I Clinical Trial 

Details: The TARGET BP I Trial is a randomized, blinded, multi-center, international, sham-procedure controlled trial, comparing renal denervation performed with the Peregrine System Kit in the treatment group to the sham control group (without renal denervation - no alcohol infusion). Subjects will be randomized in a 1:1 fashion to treatment versus sham control via central randomization


Specialty: Cardiovascular Disease

Principal Investigator: Dr Faisal Sharif

Study status: Recruiting

Identifier: NCT02910414